Cargando…
ARDD 2020: from aging mechanisms to interventions
Aging is emerging as a druggable target with growing interest from academia, industry and investors. New technologies such as artificial intelligence and advanced screening techniques, as well as a strong influence from the industry sector may lead to novel discoveries to treat age-related diseases....
Ejemplares similares
-
From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs
por: McIntyre, Rebecca L, et al.
Publicado: (2019) -
Integrating the Hallmarks of Aging Throughout the Tree of Life: A Focus on Mitochondrial Dysfunction
por: van der Rijt, Sanne, et al.
Publicado: (2020) -
Mitochondrial ubiquinone–mediated longevity is marked by reduced cytoplasmic mRNA translation
por: Molenaars, Marte, et al.
Publicado: (2018) -
Aging and drug discovery
por: Bakula, Daniela, et al.
Publicado: (2018) -
Inhibition of the neuromuscular acetylcholine receptor with atracurium activates FOXO/DAF‐16‐induced longevity
por: McIntyre, Rebecca L., et al.
Publicado: (2021)